Real-world increase in biomarker testing in lung cancer patients, registry study reveals
Origins of diabetes may be different in men and women, according to new research
23 March 2022Discovery of bitter taste receptors in the lung could pave way for new treatment
23 March 2022Real-world increase in biomarker testing in lung cancer patients, registry study reveals
More than half of patients diagnosed with advanced non-small cell lung cancer (NSCLC) undergo biomarker testing, and this figure has increased over the last five years, reveal real-world data from a Spanish national registry study reported at the European Lung Cancer Congress (ELCC), 30 March-2 April 2022. The results of this study illustrate the value of registry data for improving lung cancer care.
